Science is supposed to be self-correcting. But what happens when the journals entrusted to uphold this principle become its gatekeepers?

Benzodiazepine use is common, with research estimating as many as 12.6% of US adults report past-year use. A 2019 study found significant increases in...

A new article published in the Journal of Humanistic Psychology finds that patients often experience forced drugging in psychiatric contexts as dehumanizing and violent....

A new study published online by the Journal of Humanistic Psychology examines young adults’ experience of taking and discontinuing antipsychotic drugs after completing a...

This week Mad in America examines three studies related to adverse effects of antidepressants. The first study finds that antidepressant use is linked to...

This week Mad in America examines three studies related to the adverse effects of psychotropic drugs and one that investigates the effect of keto...

This week Mad in America explores four recently published articles related to antidepressant use in children and adolescents. The first reports that although clinical...

This week Mad in America examines studies related to adverse events associated with antipsychotics and antidepressants, including two studies that found increased risk of...

Long-term care facilities commonly prescribe antipsychotic drugs to elderly service users, often to treat behavioral issues associated with dementia. Despite a lack of evidence...

This week, Mad in America examines research around increased suicide risk in children and adolescents related to bullying in high-school and the use of...

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported biological beliefs about mental "illness," and research linking...

Response and remission rates failed to beat placebo in a new Harvard meta-analysis, throwing the inflammation hypothesis into question.

Questions remain about best practices for discontinuation strategies, and the distinction between relapse and withdrawal was not defined.

Those who received drug-tapering support did just as well or better than those receiving treatment as usual.

Psychiatric drugs linked to increased risk of the rare, incurable neurological disease that causes loss of motor function.

Researchers found that for many doctors, renewing antidepressant prescriptions feels safer and faster than helping people taper, and that most current interventions fail to address the pressures driving that choice.

There is no good evidence that antipsychotics provide a benefit to first-episode or early-episode psychotic patients.

The study shows that tapering can be successfully and relatively safely done by most people after first-episode psychosis.

The authors call for a paradigm shift in mental health care that emphasizes empathy, context, and alternatives to medication as first-line treatments for depression.

New research from Germany shows how guidelines, system pressures, and lack of collaboration limit deprescribing.